Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage among hospitalised patients with tuberculosis in rural KwaZulu-Natal by Heysell, Scott K et al.
332
ORIGINAL ARTICLES
May 2011, Vol. 101, No. 5  SAMJ
Methicillin-resistant Staphylococcus aureus (MRSA) is a serious 
global pathogen. The few reports of MRSA prevalence from Africa 
describe hospital epidemiology from large institutions in urban 
settings or aggregate data from referral laboratories.1-4 Hospitalised 
patients with TB have high rates of HIV co-infection in sub-Saharan 
Africa that may increase risk of MRSA colonisation and infection. 
In a study from Cape Town, 53 (18%) of 291 patients with TB and 
HIV infection who had clinically deteriorated had another bacterial 
infection, including MRSA.5 The presence and impact of MRSA 
among patients from rural hospitals in sub-Saharan Africa has not 
previously been studied.
KwaZulu-Natal Province has one of the highest rates of HIV 
co-infection among TB patients. At the rural hospital in Tugela Ferry, 
approximately 90% of patients admitted to the TB ward were found 
to be HIV-infected.6 Routine hospital surveillance from Tugela Ferry 
identified patients with MRSA. Therefore, we studied the prevalence 
of MRSA colonisation in patients admitted to the TB wards and 
sought to describe resistance patterns among MRSA isolates, and the 
contribution of nosocomial acquisition.
Methods
Patients and setting
Infection control staff performed a prospective prevalence survey 
of MRSA carriage among patients admitted to the adult TB wards 
at Church of Scotland Hospital in Tugela Ferry from 15 November 
to 15 December 2008. The hospital has 355 beds with occupancy of 
approximately 50 patients in both male and female TB wards. The 
hospital management and the local district’s department of health 
initiated the survey. Patients provided consent prior to assessment.
A single swab was taken from the anterior nares of patients within 
24 hours of admission to the TB wards and transported at room 
temperature to the referral microbiology laboratory, plated for culture 
on the same day and incubated at 37oC. Growth and identification 
were conducted on mannitol salt agar, with colony morphology on 
nutrient agar. The next day, suspicious colonies had a Gram stain 
performed. Identification of S. aureus was confirmed by a positive 
catalase and coagulase test. Susceptibilities were performed by 
standard disk diffusion method.7 Repeat nasal swabs were obtained 
at hospital-day 14 or upon discharge if preceding the 14 days, and the 
presence or absence of MRSA was determined for each case.
Data from medical charts included age, sex, history of prior 
hospitalisation within the last 2 years, TB treatment history, HIV 
status, CD4 count (cells/mm3) and current antibiotic exposures. Chi-
square tests were used as appropriate and Mann-Whitney U-tests for 
non-parametric variables to compare clinical characteristics among 
patients with and without MRSA on admission.
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Results. Of 52 patients with an admission nasal swab, 11 (21%) 
were positive for MRSA. An additional 4 (10%) of patients with 
negative admission swabs were positive for MRSA on repeat testing. 
MRSA carriage on admission was more common among patients 
with previous hospitalisation, and among HIV-infected patients 
was significantly associated with lower CD4 counts (p=0.03). All 
MRSA isolates were resistant to cotrimoxazole, and 74% were 
resistant to ≥5 classes of antibiotics; all retained susceptibility to 
vancomycin.
Conclusions. A high prevalence of multidrug-resistant MRSA 
nasal carriage was found. Studies are needed to validate nosocomial 
acquisition and to evaluate the impact of MRSA on morbidity and 
mortality among TB patients in similar settings.
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Results
MRSA nasal carriage
During the study, 55 patients were admitted and 52 consented for 
survey. From the admission swabs, 13 (25%) patients had S. aureus 
isolated; 11 (85%, or 21% of total) of these had MRSA (Table I), 
while the remainder were methicillin-susceptible. Of patients with 
MRSA on admission, 9/11 (82%) had been previously hospitalised, 
compared with 17/41 (41%) patients without MRSA (p=0.08). 
Among known HIV-infected patients, those with lower CD4 counts 
were significantly more likely to have MRSA on admission (p=0.03). 
At follow-up on day 14 of hospitalisation, among 41 patients initially 
negative for MRSA, 4 (10%) were positive for MRSA.
Including both admission and follow-up cultures, there were 15 
patients with MRSA who produced a total of 19 isolates. Of the 
patients with MRSA, 9 (60%) had previously received cotrimoxazole 
as part of prophylaxis for opportunistic infections. All patients with 
MRSA were receiving first-line therapy for TB with rifampicin, 
isoniazid, pyrazinamide and ethambutol. Additionally, 2 patients 
were receiving ampicillin and gentamicin, and 6 were receiving a 
cephalosporin.
MRSA resistance patterns
All 19 MRSA isolates were resistant to cotrimoxazole, penicillin, 
ampicillin and gentamicin (Table II). Of 18 isolates tested for 
susceptibility to tetracycline, 15 (83%) were resistant; 14 (74%) of 
isolates were resistant to erythromycin and, although only 12 were 
tested against clindamycin, all were susceptible. Additional testing for 
the macrolide-lincosamide-streptogramin B (MLSB) phenotype using 
the D-test among erythromycin-resistant isolates was not performed. 
All isolates were susceptible to vancomycin and 89% to fusidic acid.
Discussion
This first report of MRSA nasal carriage in hospitalised TB patients 
from rural South Africa demonstrates high admission prevalence and 
possible additional new MRSA acquisition during hospitalisation. 
Among new admissions to the TB ward, 21% were carriers of 
MRSA. Strikingly, 90% of all S. aureus isolates from the nares of 
predominantly HIV-infected patients were MRSA, a rate much 
higher than existing data from the province. In an extensive study 
of all clinical isolates of S. aureus from KwaZulu-Natal, only 27% 
were MRSA.8 Although mechanisms of resistance were unable to be 
further characterised, it is notable that HIV-infected patients with 
advanced immunosuppression were more likely to carry MRSA.
This study also suggests an ominous trend regarding susceptibility 
to other antimicrobial agents among MRSA isolates. Although only 
60% of the patients with MRSA carriage had received cotrimoxazole 
prophylaxis, all recovered MRSA isolates were resistant to 
cotrimoxazole. All MRSA isolates were resistant to ≥3 antibiotic 
classes, 79% resistant to 4 classes, and 74% resistant to 5 classes. 
Although susceptibilities to rifampicin were not performed on these 
multidrug-resistant isolates, high levels of rifampicin resistance from 
MRSA clinical isolates in KwaZulu-Natal have been noted.8
Definitive molecular investigation was not available, and the 
additional MRSA positivity found in the follow-up swabs might 
have been the result of intermittent carriage or poor technique 
on the first collection. However, among those with MRSA nasal 
carriage, available susceptibility patterns and the high rate of previous 
hospitalisation suggest nosocomial acquisition.
This small study underscores the need for larger-scale studies of the 
epidemiology of MRSA in rural South Africa, the presence of which 
has important clinical consequences. Identification of MRSA and 
reduction in empiric use of courses of expensive antibiotics that may 
not be of benefit require improved and more accessible laboratory 
capability. Unfortunately, multidrug-resistant MRSA infections may 
only remain susceptible to vancomycin or newer glycopeptides. In 
South Africa’s public sector, vancomycin is a restricted medication 
in rural hospitals and often available only upon demonstration of a 
drug-resistant organism.
We also highlight the need to implement sound infection control 
practices. Most rural hospitals in sub-Saharan Africa have limited 
resources for such implementation. Patients admitted to the Tugela 
Table I. Demographics and clinical characteristics on admis-
sion to TB ward compared by MRSA status; N=52
Characteristics MRSA (+) MRSA (-)*
Patient N (% total N) 11 (21) 41 (79)
Median age (IQR) 36 yrs (32 - 44) 35 yrs (28 - 44)
Sex
   Female (%) 6 (55) 18 (44)
   Male (%) 5 (45) 23 (56)
Hospitalised last 2 yrs (%) 9 (82)† 17 (41)
On TB treatment (%) 11 (100) 41 (100)
HIV status
   Positive (%) 9 (82) 35 (85)
   Negative 1 (9) 1 (3)
   Unknown 1 (9) 5 (12)
Median CD4 count (IQR) 37 cells/mm3  
(20 - 60)‡
127 cells/mm3 
(47 - 190) 
Receiving cotrimoxazole 
(% of HIV-infected)
7 (64) 24 (59)
*Four (10%) additional patients who were initially negative for MRSA had a positive 
follow-up culture.
†p=0.08.
‡Available in 41 (93%) HIV-infected patients, p=0.03. No other clinical characteristics 
were significantly different on admission.
IQR = interquartile range.
Table II. Susceptibility patterns of MRSA isolates; N=19
Antibiotic S I R % R
Penicillin 0 0 19 100
Ampicillin 0 0 19 100
Oxacillin 0 0 19 100
Gentamicin 0 0 19 100
Cotrimoxazole 0 0 19 100
Tetracycline 2 1 15 83
Erythromycin 5 0 14 74
Clindamycin 12 0 0 0
Fusidic acid 17 2 0 0
Vancomycin 19 0 0 0
S = susceptible; I = intermediate; R = resistant. Antibiotic disk concentrations per recom-
mendations of Clinical and Laboratory Standards Institute (formerly National Committee 
for Clinical Laboratory Standards).7
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Ferry hospital or similar district hospitals are not routinely screened 
for MRSA carriage, and neither are patients cohorted based on 
current or prior MRSA infection. Hand-washing facilities and 
practices are sub-standard. The legitimate fear of airborne TB 
transmission in similar settings might have drawn attention from 
other virulent hospital-acquired infections whose transmission is 
largely preventable by hand hygiene and identification of infectious 
hosts and carriers.
Conclusions
A high prevalence of multidrug-resistant MRSA nasal carriage was 
found among TB patients with advanced HIV admitted to a rural 
hospital in South Africa. Nosocomial transmission was suggested 
by previous hospitalisation history, similarity of antibiotic resistance 
and possible further acquisition during hospitalisation. Prospective 
studies are needed to validate the high carriage rate and nosocomial 
acquisition as well as to evaluate the impact of MRSA on morbidity 
and mortality among TB patients in similar settings, and expand the 
evidence base for enhanced microbiological and infection control 
resources, policies and practices.
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